“…Viral infections pose a constant challenge to the hosts' immune system. Researchers have applied CyTOF to explore the immune alterations of patients infected with influenza, 124 HIV, [125][126][127][128][129][130][131][132][133] Japanese Encephalitis, 134 Ebola, 135 Gammaherpesvirus, 136 chikungunya, 137 hepatitis B, 138,139 as well as the mosquito-borne human viral pathogens, including dengue [140][141][142] and Zika, 143,144 and elucidated the fates of immune cells across viral infections. The use of CyTOF has also supported recent findings in COVID-19 pathogenesis and immune perturbations, 145,146 where the results showed immunosuppression and dysfunction in PBMCs of COVID-19-infected patients.…”